What are the commercial and regulatory challenges facing CRISPR gene-edited crops?

Credit: RicardoGuimaraes via CC0-1.0
Credit: RicardoGuimaraes via CC0-1.0

When you useย CRISPRย gene editing on crop plants, you can do โ€œsome pretty cool things,โ€ says Timothy Kelliher, PhD, head of crop trait and technology discovery at Syngenta Seeds. You can change the structure of chromosomes, add large amounts of genetic material, move genes around, turn genes on and off, and fine-tune gene expression. And yet, Kelliher admits, inefficiency in bringing these cool things to commercial agricultural products is โ€œstill a problem.โ€

So, why is CRISPR gene editing facing commercial challenges? There are several answers.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

In most cases… the optimal alleles for all of the genes involved in a complex trait are unknown. So, even though there are CRISPR tools like Cas12 that allow multiplexing in one construct with multiple guides to different genomic targets, it is a biological challenge to know how to edit each gene involved in a trait and to figure out what effect the different edits have on a trait when they are all put together.

Whatโ€™s more, since there is a great deal of genetic diversity, gene redundancy, and structural variation among the chromosomes in plants, there are, Kelliher says, many examples where a gene or an edit works as desired in one crop line but has a different effect in another crop line.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
What explains Homo sapiensโ€™ huge brains? Ancient climate change played a role
Viewpoint: Internal White House documents detail administrationโ€™s strategy to undermine climate science
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-May-7-2026-11_28_04-AM-2
โ€˜Conflict entrepreneursโ€™ are driving disinformation and shaping public opinion
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
ChatGPT-Image-May-6-2026-03_41_05-PM
โ€˜Protecting the integrity of scienceโ€™: Kennedyโ€™s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDCย 
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of howย  the White House embraced the fringe claim that scientists are being mysteriously murdered

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.